SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+6.35%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$293M
AUM Growth
+$293M
(+7.2%)
Cap. Flow
+$5.45M
Cap. Flow
% of AUM
1.86%
Top 10 Holdings %
Top 10 Hldgs %
28.19%
Holding
93
New
21
Increased
25
Reduced
19
Closed
18
Top Buys
| 1 |
Danaher
DHR
|
$4.72M |
| 2 |
Zoetis
ZTS
|
$4.14M |
| 3 |
Thermo Fisher Scientific
TMO
|
$3.78M |
| 4 |
AbbVie
ABBV
|
$3.11M |
| 5 |
Zimmer Biomet
ZBH
|
$2.93M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$9.26M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$7.01M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$4.91M |
| 4 |
Merck
MRK
|
$4.81M |
| 5 |
Cardinal Health
CAH
|
$3.9M |
Sector Composition
| 1 | Healthcare | 87% |
| 2 | Financials | 2.99% |
| 3 | Energy | 1.23% |
| 4 | Industrials | 0.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Acadia Pharmaceuticals
ACAD
$4.38B
| $4.52M | 1.54% |
120,000
+65,000
| +118% | +$2.45M |
|
27
Smith & Nephew
SNN
$16.3B
| $4.37M | 1.49% |
120,000
+30,000
| +33% | +$1.09M |
|
|
VAR
28
DELISTED
Varian Medical Systems, Inc.
VAR
| $4.17M | 1.42% |
41,683
+16,683
| +67% | +$1.67M |
|
|
29
Zoetis
ZTS
$69.3B
| $4.14M | 1.41% |
+65,000
| New | +$4.14M |
|
30
McKesson
MCK
$85.4B
| $3.84M | 1.31% |
25,000
-5,000
| -17% | -$768K |
|
|
HRC
31
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $3.7M | 1.26% |
50,000
+10,000
| +25% | +$740K |
|
|
LHCG
32
DELISTED
LHC Group LLC
LHCG
| $3.61M | 1.23% |
50,910
+5,910
| +13% | +$419K |
|
33
Intuitive Surgical
ISRG
$170B
| $3.4M | 1.16% |
3,250
| – | – |
|
|
IPXL
34
DELISTED
Impax Laboratories, Inc.
IPXL
| $3.35M | 1.14% |
165,000
-85,000
| -34% | -$1.73M |
|
35
Cencora
COR
$56.5B
| $3.31M | 1.13% |
40,000
-15,000
| -27% | -$1.24M |
|
|
AMED
36
DELISTED
Amedisys
AMED
| $3.08M | 1.05% |
55,000
+10,393
| +23% | +$582K |
|
37
Illumina
ILMN
$15.8B
| $2.99M | 1.02% |
15,000
+5,000
| +50% | +$996K |
|
|
38
Zimmer Biomet
ZBH
$21B
| $2.93M | 1% |
+25,000
| New | +$2.93M |
|
39
Idexx Laboratories
IDXX
$51.8B
| $2.72M | 0.93% |
+17,500
| New | +$2.72M |
|
40
Bio-Techne
TECH
$8.5B
| $2.58M | 0.88% |
+21,339
| New | +$2.58M |
|
|
GWPH
41
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $2.54M | 0.86% |
25,000
-5,000
| -17% | -$507K |
|
42
Chemed
CHE
$6.67B
| $2.53M | 0.86% |
12,500
| – | – |
|
43
Bausch Health
BHC
$2.74B
| $2.51M | 0.85% |
175,000
-70,000
| -29% | -$1M |
|
44
Align Technology
ALGN
$10.3B
| $2.5M | 0.85% |
+13,400
| New | +$2.5M |
|
|
CLVS
45
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.47M | 0.84% |
30,000
+10,000
| +50% | +$824K |
|
|
JUNO
46
DELISTED
Juno Therapeutics, Inc.
JUNO
| $2.47M | 0.84% |
+55,000
| New | +$2.47M |
|
|
BLUE
47
DELISTED
bluebird bio
BLUE
| $2.4M | 0.82% |
17,500
+2,500
| +17% | +$343K |
|
48
Puma Biotechnology
PBYI
$254M
| $2.4M | 0.81% |
20,000
| – | – |
|
49
Encompass Health
EHC
$12.3B
| $2.36M | 0.8% |
+50,912
| New | +$2.36M |
|
|
LOXO
50
DELISTED
Loxo Oncology, Inc
LOXO
| $2.3M | 0.78% |
25,000
+4,500
| +22% | +$415K |
|